|
gptkbp:instanceOf
|
Controlled substance schedule
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:describes
|
Drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence
|
|
gptkbp:example
|
gptkb:Cocaine
gptkb:Adderall
gptkb:Amphetamine
gptkb:Hydrocodone
gptkb:Hydromorphone
gptkb:Meperidine
gptkb:Methylphenidate
gptkb:Morphine
gptkb:Oxycodone
gptkb:Pentobarbital
gptkb:Secobarbital
Methamphetamine
Fentanyl
|
|
gptkbp:fullName
|
gptkb:Schedule_II_controlled_substance
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
C-II
|
|
gptkbp:legalStatus
|
Prescription only
|
|
gptkbp:medicalUse
|
Accepted medical use in treatment in the United States
|
|
gptkbp:potentialForAbuse
|
High
|
|
gptkbp:prescriptionRequired
|
Written prescription required
|
|
gptkbp:refillPolicy
|
No refills allowed
|
|
gptkbp:regulates
|
gptkb:Drug_Enforcement_Administration
gptkb:United_States_federal_law
|
|
gptkbp:scheduleUnder
|
gptkb:Controlled_Substances_Act
|
|
gptkbp:bfsParent
|
gptkb:Schedule_II_controlled_substances
|
|
gptkbp:bfsLayer
|
7
|